Form 8-K - Current report:
SEC Accession No. 0001144204-14-072404
Filing Date
2014-12-05
Accepted
2014-12-04 18:04:04
Documents
26
Period of Report
2014-12-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v395879_8k.htm 8-K 15916
2 EXHIBIT 99.1 v395879_ex99-1.htm EX-99.1 42914
3 GRAPHIC image_001.jpg GRAPHIC 43036
4 GRAPHIC image_002.jpg GRAPHIC 132873
5 GRAPHIC image_003.jpg GRAPHIC 118949
6 GRAPHIC image_004.jpg GRAPHIC 115500
7 GRAPHIC image_005.jpg GRAPHIC 158501
8 GRAPHIC image_006.jpg GRAPHIC 106892
9 GRAPHIC image_007.jpg GRAPHIC 125138
10 GRAPHIC image_008.jpg GRAPHIC 116964
11 GRAPHIC image_009.jpg GRAPHIC 116965
12 GRAPHIC image_010.jpg GRAPHIC 125705
13 GRAPHIC image_011.jpg GRAPHIC 132864
14 GRAPHIC image_012.jpg GRAPHIC 110076
15 GRAPHIC image_013.jpg GRAPHIC 129134
16 GRAPHIC image_014.jpg GRAPHIC 107168
17 GRAPHIC image_015.jpg GRAPHIC 86912
18 GRAPHIC image_016.jpg GRAPHIC 85485
19 GRAPHIC image_017.jpg GRAPHIC 95256
20 GRAPHIC image_018.jpg GRAPHIC 109383
21 GRAPHIC image_019.jpg GRAPHIC 136921
22 GRAPHIC image_020.jpg GRAPHIC 131981
23 GRAPHIC image_021.jpg GRAPHIC 120236
24 GRAPHIC image_022.jpg GRAPHIC 124001
25 GRAPHIC image_023.jpg GRAPHIC 64364
26 GRAPHIC image_024.jpg GRAPHIC 117460
  Complete submission text file 0001144204-14-072404.txt   3799889
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141267392
SIC: 2834 Pharmaceutical Preparations